April 23, 2020   Sweden
Umeå Biotech Incubator on Diamyd Medical´s plans to open up a new vaccine manufacturing facility
Publicly listed Diamyd Medical is to open a new vaccine manufacturing facility in Umeå.

“This is fantastic news and demonstrates that Umeå is a growing life science hub,” says Jennie Ekbeck, CEO of Umeå Biotech Incubator.

Read the press release here
Information presented here are not press releases and may include excerpts from and links to externally published content. Diamyd Medical is not responsible for externally published content.

Order GAD for preclinical research